Literature DB >> 10449683

Lymph node dissection for gastric cancer.

H J Meyer1, J Jähne.   

Abstract

Complete tumor removal with margins of clearance at the resection lines must be the aim of today's surgical treatment of gastric cancer, and this must be applied even in lymph node dissection. But, over the last few decades, the extent and impact of lymphadenectomy remains controversial. Whereas Japanese centers advocate extensive lymph node dissection as the base of their excellent results, many Western surgeons, supported by actual randomized trials, believe that the potential benefit of such procedures cannot outweigh the risk of increased postoperative morbidity and mortality. However, if lymphadenectomy is restricted to the removal of nodes only, it does not influence the operative risk. Further, the lymph node ratio and number of lymph nodes involved are relevant prognostic parameters. Survival improvement can be achieved in a moderate degree of metastatic involvement of the nodes (pN0,1). Therefore, systematic lymph node dissection should be an integral part of the curative resection sought. Limited or no lymphadenectomy might be indicated in noncurative surgery or in special types of mucosal early gastric cancer, respectively. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10449683     DOI: 10.1002/(sici)1098-2388(199909)17:2<117::aid-ssu6>3.0.co;2-7

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  1 in total

1.  Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy.

Authors:  Dao-Jun Gong; Chao-Feng Miao; Qi Bao; Ming Jiang; Li-Fang Zhang; Xiao-Tao Tong; Li Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.